Author Profile
Dow, Ethan
Reversing Sickle Cell Disease: A Crisp Deal?
Matherne, G. (Paul); Herpfer, Christoph; Dow, Ethan
OM-1795 | Published November 12, 2025 | 11 Pages Case
Collection: Darden School of Business
Carmen Jones, principal at a venture capital firm in the biotechnology industry, pondered the latest deal the firm was considering. It had recently closed a $700 million fund and was evaluating severa... Read More
Venture Capital in Biotechnology
Matherne, G. (Paul); Herpfer, Christoph; Dow, Ethan
OM-1796 | Published December 05, 2023 | 8 pages Technical Note
Collection: Darden School of Business
Pharmaceutical companies have historically relied on their ability to research, develop, manufacture, and sell drug products. Developing a successful drug is a complex and lengthy process, with no gua... Read More